Sonova stock holds steady after fiscal 2025 growth

Sonova Holding AG (CH0012549785) is anchored by fiscal 2025 revenue of CHF 3.87 billion, EBIT of CHF 805.1 million, and net income of CHF 547.3 million, with basic EPS of CHF 8.97. The company remains the Swiss hearing-care leader on the SIX, and those full-year numbers define the stock story more clearly than any short-lived headline.

CHF 3.87 billion in revenue

For fiscal 2025, Sonova reported revenue of CHF 3.87 billion and EBIT of CHF 805.1 million, which put operating profit at about 20.8% of sales. Net income reached CHF 547.3 million and basic EPS came to CHF 8.97, giving investors a clean profit base to compare with the prior year.

The comparison matters because Sonova said revenue was up 7.4% year on year in local currencies, while EBIT rose 8.5% at constant exchange rates. That combination points to growth that was not only top-line driven but also supported by leverage in the business.

Margin near 21%

Sonova's fiscal 2025 EBIT margin of roughly 20.8% is the number that matters most for valuation discipline. A business that can keep operating profitability around that level while still expanding sales has more room to absorb exchange-rate swings and mix changes.

The company also stated that basic EPS of CHF 8.97 was above the prior year, which ties earnings quality to the revenue and EBIT trend. For a stock like Sonova, the market usually rewards earnings consistency more than a single quarter's noise.

Hearing aids stay central

Sonova's core hearing-aid franchise remains the main engine behind the fiscal 2025 result, even as the group also serves the broader hearing-care chain. That matters because the group is not a one-product story: its revenue mix gives the market multiple ways to read the same annual print.

The numbers in the annual report suggest a company that kept growing while protecting profitability. Revenue of CHF 3.87 billion, EBIT of CHF 805.1 million, and net income of CHF 547.3 million together show a business that still converts scale into earnings.

Price anchors the valuation

Sonova stock trades on the SIX, where the latest market context should be read against the fiscal 2025 base. The business delivered CHF 3.87 billion in sales and CHF 805.1 million in EBIT, so even a modest change in margins or growth can shift the valuation debate.

As a plain valuation frame, the share price needs to be judged against the company's CHF 547.3 million net income and CHF 8.97 basic EPS for fiscal 2025. That is the earnings backdrop investors use when they test whether the stock is priced for steady execution or for a slower operating path.